Papers: 10 Sep 2012 - 17 Sep 2012
Neutralizing Antibodies Are Associated with a Reduction of Interferon-β Efficacy during the Treatment of Japanese Multiple Sclerosis Patients.
Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system.
The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
Blood-Brain Barrier Disruption is More Severe in Neuromyelitis Optica than in Multiple Sclerosis and Correlates with Clinical Disability.
Rapid exacerbation of multiple sclerosis following the initiation of interferon-β: report of nine cases.
Treatment of Neurological Autoimmune Diseases with Immunoglobulins: First Insights from the Prospective SIGNS Registry.
Anti-phospholipid antibodies are associated with response to interferon-beta1a treatment in MS: results from a 3-year longitudinal study.
Characteristics of flow through the internal jugular veins at cervical C2/C3 and C5/C6 levels for multiple sclerosis patients using MR phase contrast imaging.
A technical approach to dissecting and assessing cadaveric veins pertinent to chronic cerebrospinal venous insufficiency in multiple sclerosis.
Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects.
Evaluation of the Effect of Progressive Relaxation Exercises on Fatigue and Sleep Quality in Patients with Multiple Sclerosis.
Cerebral vein changes in relapsing-remitting multiple sclerosis demonstrated by three-dimensional enhanced T (2) (*) -weighted angiography at 3.0 T.
[Antidepressants for treatment of depression in palliative patients : A systematic literature review.]
[Treatment of nausea and vomiting with prokinetics and neuroleptics in palliative care patients : A review.]
Initiation of Anti-TNF Therapy and the Risk of Optic Neuritis; From the Safety Assessment of Biologic ThERapy (SABER) Study.
Impact of cerebrospinal-fluid oligoclonal immunoglobulin bands and HLA-DRB1 risk alleles on brain magnetic-resonance-imaging lesion load in Swedish multiple sclerosis patients.
Internet-based self-help treatment for depression in multiple sclerosis: study protocol of a randomized controlled trial.
MHC Mismatch Results in Neural Progenitor Cell Rejection Following Spinal Cord Transplantation in a Model of Viral-Induced Demyelination.
Differential Cerebellar Functional Interactions during an Interference Task across Multiple Sclerosis Phenotypes.
Serum antibodies to 25 myelin oligodendrocyte glycoprotein epitopes in multiple sclerosis and neuromyelitis optica: clinical value for diagnosis and disease activity.
Treatment satisfaction and improvement in health-related quality of life with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity.
Fingolimod (FTY720) inhibits neuroinflammation and attenuates spontaneous convulsions in lithium-pilocarpine induced status epilepticus in rat model.
Multiple sclerosis: Diurnal variations in serum markers of inflammation-an avoidable source of bias in MS studies?
Further validation of Multiple Sclerosis Walking Scale-12 scores based on spatiotemporal gait parameters.
Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression.
Impact of Armodafinil on Cognition in Multiple Sclerosis: A Randomized, Double-blind Crossover Pilot Study.
Chronic cerebrospinal venous insufficiency is not more prevalent in patients with mild multiple sclerosis: a sonographer-blinded, case-control ultrasound study.
Transgenic inhibition of astroglial NF-kappaB protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis.
Absence of Multiple Sclerosis and Demyelinating Diseases among Lacandonians, a Pure Amerindian Ethnic Group in Mexico.